IIP
BIIB icon

Intermede Investment Partners’s Biogen BIIB Stock Holding History

Intermede Investment Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-104,117
Closed -$31.3M – 26
2018
Q4 		$31.3M Sell
104,117
-26,996
-21% -$8.62M 2.5% 22
2018
Q3 		$46.3M Buy
131,113
+6,062
+5% +$2.09M 3.47% 18
2018
Q2 		$36.3M Sell
125,051
-4,193
-3% -$1.18M 2.87% 21
2018
Q1 		$35.4M Sell
129,244
-7,713
-6% -$2.39M 3.04% 18
2017
Q4 		$43.6M Buy
136,957
+6,450
+5% +$2.07M 3.71% 15
2017
Q3 		$40.9M Buy
130,507
+23,287
+22% +$6.9M 3.74% 17
2017
Q2 		$29.1M Buy
107,220
+83
+0.1% +$21.9K 2.81% 21
2017
Q1 		$29.3M Buy
107,137
+46,592
+77% +$13.2M 3.06% 20
2016
Q4 		$17.2M Sell
60,545
-15,635
-21% -$4.63M 2.01% 26
2016
Q3 		$23.8M Buy
76,180
+917
+1% +$272K 2.64% 22
2016
Q2 		$18.2M Sell
75,263
-12,869
-15% -$3.39M 2.11% 25
2016
Q1 		$22.9M Buy
88,132
+17,742
+25% +$4.69M 2.76% 21
2015
Q4 		$21.6M Buy
+70,390
New +$20.2M 3.65% 15

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Intermede Investment Partners's BIIB Position: Q1 2019 in Review

Intermede Investment Partners sold out of Biogen (BIIB) in Q1 2019, closing a stake of 104,117 shares — an estimated $31.3M sold.

Intermede Investment Partners first reported a position in BIIB in Q4 2015 and held it in 13 quarters. The position peaked at $46.3M in Q3 2018. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Intermede Investment Partners reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Intermede Investment Partners sold 104,117 Biogen shares in Q1 2019, an estimated $31.3M.
  • Intermede Investment Partners first reported a position in Biogen in Q4 2015 and held it in 13 quarters.
  • Intermede Investment Partners's Biogen position peaked at $46.3M in Q3 2018.
  • 1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Intermede Investment Partners's 13F filing for Q1 2019, filed 1 May 2019.